Efficacy, Safety, and Tolerability Study of Infliximab in Juvenile Spondyloarthropathies

Clinical trial NCT00591201 · COMPLETED

Trial details

NCT number: NCT00591201
Sponsor: Hospital General de Mexico
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Spondylarthropathies

Start date: 2002-06-01
Primary completion: 2007-06-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.